Who is sponsoring NCT03903471?

NCT03903471 is sponsored by Jiayuan Sun.

What drugs are being tested in NCT03903471?

Interventions in NCT03903471: 22G-ProCore Endobronchial Ultrasound Needle, 22G-Standard Endobronchial Ultrasound Needle.

What condition does NCT03903471 study?

NCT03903471 studies Lymph Node Disease.

Is NCT03903471 still recruiting?

NCT03903471 is currently status unknown. Last updated 29 September 2022.

Last reviewed 2022-09-29 · How we verify

NCT03903471

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA

Status unknown NA Last updated 29 September 2022

What this trial tests

NA trial testing 22G-ProCore Endobronchial Ultrasound Needle in Lymph Node Disease in 600 participants. Status unknown.

Timeline

8 October 2022

Primary endpoint
8 October 2023

8 October 2023

Quick facts

Lead sponsor	Jiayuan Sun
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	600
Start date	8 October 2022
Primary completion	8 October 2023
Estimated completion	8 October 2023
Sites	1 location across China

Drugs / interventions tested

22G-ProCore Endobronchial Ultrasound Needle
22G-Standard Endobronchial Ultrasound Needle

Conditions studied

Lymph Node Disease — all drugs for Lymph Node Disease →

Sponsor

Jiayuan Sun

Who can join

18 and older, any sex, with Lymph Node Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the performance of 22G-ProCore and 22G-Standard needle in diagnosis of mediastinal and hilar lymphadenopathy via EBUS-TBNA with the purpose to explore the optimal technique for obtaining diagnostic material.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Jiayuan Sun trials

Trials by the same sponsor.

NCT07277088 — The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy · NA · not yet recruiting
NCT06572540 — Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer · NA · recruiting
NCT05771129 — Feasibility Study of the Pulsed Electric Field Ablation System in Treating Chronic Bronchitis · NA · unknown
NCT04413669 — Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen · NA · unknown
NCT04182152 — Bronchoscopic ICG Injection and Percutaneous Hook-wire Techniques for Preoperative Lung Nodule Localization in VATS · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03903471 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jiayuan Sun
Last refreshed: 29 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03903471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing